Ji-Yoon Noh Selected Research

Ji-Yoon Noh Research Topics

Disease

11	Thrombosis (Thrombus) 05/2017 - 12/2007
8	Neoplasms (Cancer) 06/2022 - 08/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 09/2014 - 12/2007
4	Venous Thrombosis (Deep-Vein Thrombosis) 10/2011 - 12/2007
2	Hypertension (High Blood Pressure) 09/2014 - 09/2011
2	Anemia 07/2011 - 05/2010
2	Parkinson Disease (Parkinson's Disease) 05/2009 - 07/2008
1	Obesity 06/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Hematologic Neoplasms (Hematological Malignancy) 10/2020
1	Osteoporosis 10/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2018
1	Coronary Disease (Coronary Heart Disease) 01/2016
1	Atherosclerosis 01/2016
1	Fibrosis (Cirrhosis) 02/2015
1	Hypercholesterolemia 04/2014
1	Vascular Remodeling 04/2014
1	Hemorrhage 12/2012
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 12/2012
1	Sepsis (Septicemia) 08/2010
1	Edema (Dropsy) 01/2010
1	Inflammation (Inflammations) 01/2010
1	Pain (Aches) 01/2010
1	Hyperalgesia 01/2010
1	Hemolysis 01/2010
1	Alcoholism (Alcohol Abuse) 07/2008

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2010
4	PhosphatidylserinesIBA 07/2011 - 09/2009
3	CollagenIBA 12/2012 - 10/2006
3	ArsenicIBA 09/2011 - 12/2007
3	monomethylarsonous acidIBA 09/2011 - 11/2008
2	ThioredoxinsIBA 12/2020 - 11/2018
2	CytokinesIBA 01/2020 - 01/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 04/2014
2	Adenosine Diphosphate (ADP)IBA 12/2012 - 10/2006
2	Drinking WaterIBA 11/2008 - 12/2007
1	ginsenoside Rg3IBA 06/2022
1	AntioxidantsIBA 06/2022
1	palbociclibIBA 01/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	quemliclustatIBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Cyclin-Dependent Kinase 4IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 12/2018
1	fludarabineIBA 11/2018
1	XenobioticsIBA 05/2017
1	LipidsIBA 01/2016
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2015
1	IronIBA 02/2015
1	CalciumIBA 09/2014
1	Emodin (Archin)IBA 09/2014
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 04/2014
1	Simvastatin (Zocor)FDA LinkGeneric 04/2014
1	Oxidoreductases (Dehydrogenase)IBA 04/2014
1	Thrombin FDA Link 12/2012
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2012
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2012
1	ferric chlorideIBA 12/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2011
1	Porphobilinogen Synthase (delta-Aminolevulinate Dehydratase)IBA 07/2011
1	Heme (Haem)IBA 07/2011
1	SilverIBA 06/2011
1	1-dodecylpyridoxal (PLD)IBA 08/2010
1	Phospholipase DIBA 08/2010
1	Phosphatidic Acids (Phosphatidic Acid)IBA 08/2010
1	Sulfhydryl Compounds (Thiols)IBA 07/2010
1	MercuryIBA 07/2010
1	NaphthoquinonesIBA 05/2010
1	Pharmaceutical PreparationsIBA 05/2010
1	Analgesics (Analgesic Drugs)IBA 01/2010
1	loganinIBA 01/2010
1	SaponinsIBA 01/2010
1	TanninsIBA 01/2010
1	swerosideIBA 01/2010
1	Arachidonic Acid (Vitamin F)IBA 01/2010
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2010
1	Croton OilIBA 01/2010
1	CarrageenanIBA 01/2010
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 05/2009
1	Adenosine Triphosphate (ATP)IBA 05/2009
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 05/2009
1	Arsenicals (Arsenic Compounds)IBA 11/2008
1	NeurotoxinsIBA 07/2008

Therapy/Procedure

4	Immunotherapy 01/2022 - 01/2020
4	Therapeutics 11/2021 - 10/2015
2	Drug Therapy (Chemotherapy) 11/2021 - 11/2011
1	Investigational Therapies (Experimental Therapy) 10/2020
1	Intravenous Injections 10/2015
1	Oral Administration 10/2011
1	Injections 01/2010